Resmed Inc (RMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2026 | 06-2025 | 06-2024 | 06-2023 | 06-2022 | |
| Sales | 5,653,443 | 5,146,327 | 4,685,297 | 4,222,993 | 3,578,127 |
| Cost of Goods | 2,201,704 | 2,091,357 | 2,029,994 | 1,867,331 | 1,553,816 |
| Gross Profit | 3,451,739 | 3,054,970 | 2,655,303 | 2,355,662 | 2,024,311 |
| Operating Expenses | 1,565,728 | 1,369,964 | 1,336,404 | 1,224,122 | 1,024,841 |
| Operating Income | 1,886,715 | 1,685,363 | 1,319,893 | 1,131,871 | 1,000,286 |
| Interest Expense | -49,914 | -4,114 | 45,708 | 47,379 | 22,312 |
| Other Income | -17,213 | -11,911 | -9,387 | 17,172 | -17,491 |
| Pre-tax Income | 1,919,416 | 1,677,566 | 1,264,798 | 1,101,664 | 960,483 |
| Income Tax | 396,123 | 276,843 | 243,847 | 204,108 | 181,046 |
| Net Income Continuous | 1,523,293 | 1,400,723 | 1,020,951 | 897,556 | 779,437 |
| Net Income | $1,523,293 | $1,400,723 | $1,020,951 | $897,556 | $779,437 |
| EPS Basic Total Ops | 10.47 | 9.55 | 6.94 | 6.12 | 5.34 |
| EPS Basic Continuous Ops | 10.47 | 9.55 | 6.94 | 6.12 | 5.34 |
| EPS Diluted Total Ops | 10.43 | 9.51 | 6.92 | 6.09 | 5.30 |
| EPS Diluted Continuous Ops | 10.43 | 9.51 | 6.92 | 6.09 | 5.30 |
| EPS Diluted Before Non-Recurring Items | 11.17 | 9.55 | 7.72 | 6.44 | 5.79 |
| EBITDA(a) | $2,130,867 | $1,921,174 | $1,536,102 | $1,329,433 | $1,194,127 |